MAS operational efficiency, investment in new products and inorganic drive position it for long-term growth and investor returns.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MAS' divestiture of Kichler Lighting focuses on core strengths, boosting the stock's potential.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Masco's (MAS) second-quarter 2024 results benefit from operational improvements.
While the top- and bottom-line numbers for Masco (MAS) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Masco (MAS) came out with quarterly earnings of $1.20 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.19 per share a year ago.
Masco's (MAS) second-quarter results are likely to reflect inflationary pressure and demand softness.
French investment firm Ardian has bought a majority stake in Italian pharmaceutical and biotech company Masco, the firms said on Monday, in a deal which two sources said gave an enterprise value of around 700 million euros ($762 million) for the stake.